Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: September 21, 2005
Last updated: September 20, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2006
  Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)